Unlocking the potential of the next generation of clinical trials will require transformative change in how we approach collecting and managing clinical data. As we move beyond CRFs and embrace eSource, committing to collecting structured data will be vital. With structured data, data ontologies can both increase the usefulness of the data collected, and reveal previously-hidden insights, but only if we are willing to make the investment.
Join Kimberly Tableman, Chief Clinical Development Officer of Castor as she discusses the current state of clinical data management and how decentralized clinical trials (DCT) can take us into the new era of clinical trials.
What we will discuss:
- Why DCT (decentralized clinical trials)?
- The evolution and benefits of eSource
- Why using paper CRFs is an obstacle to realizing DCT
- Data ontologies for next-generation data insights
